Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study

• Asıl Yazarlar: Jacopo Troisi (Yazar), Claudia Cinque (Yazar), Luigi Giugliano (Yazar), Steven Symes (Yazar), Sean Richards (Yazar), David Adair (Yazar), Pierpaolo Cavallo (Yazar), Laura Sarno (Yazar), Giovanni Scala (Yazar), Maria Caiazza (Yazar), Maurizio Guida (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2019-03-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Polycystic ovarian syndrome (PCOS) is a highly variable syndrome and one of the most common female endocrine disorders. Although the association inositols-glucomannan may represent a good therapeutic strategy in the treatment of PCOS women with insulin resistance, the effect of i...